Medi Caps quarterly results and financials

Medi Caps (MEDICAPQ)₹21.08−3.61%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Medi Caps reported sales of ₹2.80 Cr, up 3.7% from Jun 2025, and net profit of −₹2.22 Cr. For the year to Mar 2026, sales were ₹12.49 Cr and net profit −₹3.03 Cr.

Sales (Jun 2026): ₹2.80 Cr
Net profit (Jun 2026): −₹2.22 Cr
Sales (FY Mar 2026): ₹12.49 Cr
Net profit (FY Mar 2026): −₹3.03 Cr
EPS (Jun 2026): ₹−1.78
Borrowings (Mar 2026): ₹0 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Medi Caps quarterly results

₹ crore unless stated; each column is a quarter.

Medi Caps Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	6.04	7.09	7.90	6.22	8.31	4.03	6.99	2.70	2.03	4.31	3.46	2.80
Expenses	5.52	6.36	8.35	6.47	7.82	5.78	7.18	6.05	4.92	5.34	5.50	4.61
Operating Profit	0.49	0.69	−0.49	−0.27	0.44	−1.77	−0.22	−3.37	−2.90	−1.05	−2.05	−1.84
OPM %	8.3%	10.0%	−6.3%	−4.5%	5.5%	−44.2%	−3.3%	−125.6%	−144.0%	−24.6%	−59.6%	−65.6%
Other Income	0.08	0.10	0.25	0.16	0.30	0.17	2.15	0.34	1.54	0.77	5.60	0.06
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Depreciation	0.46	0.46	0.34	0.44	0.44	0.44	0.45	0.45	0.45	0.45	0.51	0.46
Profit before tax	0.11	0.33	−0.58	−0.55	0.30	−2.04	1.44	−3.48	−1.81	−0.73	3.02	−2.22
Tax %	0.0%	150.0%	83.1%	0.0%	0.0%	0.0%	−18.6%	0.0%	0.0%	4.0%	−0.3%	0.0%
Net Profit	0.11	−0.15	−1.07	−0.55	0.30	−2.04	1.71	−3.48	−1.81	−0.76	3.03	−2.22
EPS (Rs)	0.09	−0.14	−0.86	−0.46	0.24	−1.63	1.39	−2.79	−1.45	−0.61	2.43	−1.78

Medi Caps profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Medi Caps Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	43.09	44.16	53.84	51.96	43.20	57.61	70.10	49.53	27.44	25.55	12.49	12.60
Expenses	40.24	42.32	51.36	46.92	49.69	46.31	59.59	44.06	27.28	27.19	21.80	20.37
Operating Profit	2.62	1.60	2.16	4.71	−6.74	10.96	10.06	5.18	0.00	−1.79	−9.40	−7.84
OPM %	6.1%	3.7%	4.1%	9.1%	−15.6%	19.2%	14.5%	10.6%	0.0%	−7.0%	−75.5%	−62.2%
Other Income	0.69	2.03	1.08	2.74	2.87	1.78	1.96	1.50	0.49	2.74	8.22	7.97
Interest	0.05	0.09	0.09	0.12	0.11	0.09	0.10	0.12	0.03	0.04	0.01	0.00
Depreciation	1.81	1.82	1.80	1.83	1.84	1.53	1.82	1.75	1.70	1.73	1.82	1.87
Profit before tax	1.42	1.71	1.34	5.48	−5.82	11.08	10.06	4.79	−1.24	−0.83	−3.02	−1.74
Tax %	39.2%	20.3%	14.8%	2.2%	0.2%	−0.1%	0.1%	63.7%	80.0%	−32.1%	0.7%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	2.01	8.03	—
Net Profit	0.85	1.36	1.14	5.38	−5.84	11.11	10.06	1.75	−2.23	−0.56	−3.03	−1.76
EPS (Rs)	0.70	1.09	0.93	4.31	−4.70	8.92	8.07	1.42	−1.79	−0.47	−2.43	−1.41
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Medi Caps balance sheet

₹ crore, at each year end.

Medi Caps Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12.47	12.49	12.48	12.47	12.47	12.46	12.47	12.48	12.47	12.46	12.46	12.46
Reserves	68.84	69.76	76.54	77.65	83.08	78.36	92.11	104	106	108	109	99.01
Borrowings	0.82	0.09	0.10	0.18	0.13	0.07	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	6.97	10.68	8.15	10.46	10.84	4.18	10.06	14.06	7.38	6.28	4.12	3.83
Total Liabilities	89.10	93.02	97.27	101	107	95.07	115	130	126	127	125	115
Fixed Assets	57.90	56.33	61.99	60.88	59.68	57.18	57.98	59.21	58.77	58.55	57.08	56.17
CWIP	0.00	0.00	0.00	0.00	0.00	0.96	0.53	0.23	0.00	0.00	0.07	0.00
Investments	5.42	6.72	7.80	11.14	16.30	21.92	29.31	30.60	31.96	38.25	42.88	34.72
Other Assets	25.78	29.97	27.48	28.74	30.54	15.01	26.82	40.19	35.08	30.31	25.17	24.41
Inventories	13.50	15.00	13.26	10.19	10.96	5.46	6.73	11.87	7.08	5.75	3.21	2.95
Trade receivables	8.63	9.70	8.92	13.02	12.83	4.40	6.38	10.05	8.44	10.81	8.78	6.91
Cash & equivalents	0.91	1.31	2.14	2.33	2.49	1.26	6.80	9.76	1.12	0.33	0.40	0.49
Total Assets	89.10	93.02	97.27	101	107	95.07	115	130	126	127	125	115

Medi Caps cash flow

₹ crore, for each year.

Medi Caps Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	7.06	2.60	4.03	4.21	5.97	4.64	15.36	7.04	−6.10	6.95	5.08	−7.03
Cash from investing activity	−6.98	−1.48	2.58	−4.10	−5.76	−5.81	−9.72	−4.09	−2.57	−7.75	−4.99	7.12
Cash from financing activity	0.00	−0.74	−5.77	0.09	−0.06	−0.07	−0.07	0.00	0.00	0.00	0.00	0.00
Net cash flow	0.09	0.40	0.84	0.21	0.17	−1.24	5.57	2.96	−8.65	−0.80	0.10	0.10
Capex	0.51	0.17	0.73	0.70	0.60	1.26	2.27	2.80	1.17	0.36	0.34	0.86
Free cash flow	6.59	2.44	9.12	3.52	5.36	3.39	13.07	4.24	−7.25	6.60	4.75	−7.88
CFO / OP %	−9,750.0%	120.0%	269.9%	202.0%	128.0%	−69.1%	139.9%	69.9%	−58.0%	—	−267.1%	73.9%

Medi Caps ratios

Working-capital days and returns, by year.

Medi Caps Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	87	82	74	89	91	37	41	53	63	144	126	203
Inventory days	266	257	230	148	164	75	83	157	122	243	121	210
Days payable	66	102	76	91	96	27	77	154	49	77	60	34
Cash conversion cycle	287	238	229	146	158	86	47	55	136	310	187	378
Working capital days	183	153	146	112	126	84	64	87	200	323	303	597
ROCE %	−0.7%	1.8%	1.5%	1.6%	5.8%	−6.6%	11.5%	8.7%	3.7%	−1.2%	−2.1%	−9.3%

Medi Caps: frequently asked questions

What are the latest quarterly results of Medi Caps?

For the Jun 2026 quarter, Medi Caps reported sales of ₹2.80 Cr, up 3.7% year on year and net profit of −₹2.22 Cr. The operating margin was −65.6%.

What is the annual revenue of Medi Caps?

Medi Caps' sales for the year to Mar 2026 were ₹12.49 Cr; over the last twelve months they were ₹12.60 Cr.

What is the net profit of Medi Caps?

Net profit for the year to Mar 2026 was −₹3.03 Cr, and −₹1.76 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.41.

How much debt does Medi Caps have?

Medi Caps reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.49 Cr.

What is the free cash flow of Medi Caps?

Cash from operations was −₹7.03 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹7.88 Cr.

Loading…